Trial intelligence / Profile preview

PREMIUM: Metformin for Metabolic Syndrome Prevention in Prostate Cancer

NCT01996696Phase 2Terminated

Sponsor
American Health Staffing Group
Start
Sep 2014
Primary completion
Nov 2020
Countries
1
01

Overview

A Phase 2 trial of liquid metformin (Aspargo Labs) in metabolic syndrome, obesity, sponsored by American Health Staffing Group. Started Sep 2014; status: terminated.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

metabolic syndromeobesity

Beyond the preview

Go deeper on NCT01996696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01996696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call